Profiling human blood serum metabolites by nuclear magnetic resonance spectroscopy: a comprehensive tool for the evaluation of hemodialysis efficiency

Translational Research

Volumn 171, Issue , 2016, Pages 71-82.e9

  Kromke, Marika ^a   Palomino Schätzlein, Martina ^a   Mayer, Horst ^a   Pfeffer, Stefan ^a   Pineda Lucena, Antonio ^a   Luy, Burkhard ^a   Hausberg, Martin ^a   Muhle Goll, Claudia ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; COHORT ANALYSIS; END STAGE RENAL DISEASE; FEMALE; HEMODIALYSIS; HUMAN; MALE; METABOLITE; NUCLEAR MAGNETIC RESONANCE SPECTROMETER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PILOT STUDY; PRIORITY JOURNAL; SERUM; CLASSIFICATION; DIABETES MELLITUS; DISCRIMINANT ANALYSIS; LEAST SQUARE ANALYSIS; METABOLISM; METABOLOME; MULTIVARIATE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE;

DIABETES MELLITUS; DISCRIMINANT ANALYSIS; HUMANS; LEAST-SQUARES ANALYSIS; METABOLOME; MULTIVARIATE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PROTON MAGNETIC RESONANCE SPECTROSCOPY; RENAL DIALYSIS; SERUM;

EID: 84959272484     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2016.02.003     Document Type: Article

References (48)

1. M.A. Niewczas, T.L. Sirich, A.V. Mathew, and et al. Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study Kidney Int 85 2014 1214 1224
2. P. Goldwasser, N. Mittman, A. Antignani, and et al. Predictors of mortality in hemodialysis patients J Am Soc Nephrol 3 1993 1613 1622
3. W.J. Johnson, W.W. Hagge, R.D. Wagoner, R.P. Dinapoli, and J.W. Rosevear Effects of urea loading in patients with far-advanced renal failure Mayo Clin Proc 47 1972 21 29
4. R. Vanholder, R. De Smet, G. Glorieux, and et al. Review on uremic toxins: classification, concentration, and interindividual variability Kidney Int 63 2003 1934 1943
5. R.C. Vanholder, R.V. Desmet, and S.M. Ringoir Assessment of urea and other uremic markers for quantification of dialysis efficacy Clin Chem 38 1992 1429 1436
6. S. Eloot, A. Torremans, R. De Smet, and et al. Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds Kidney Int 67 2005 1566 1575
7. P.J. Foxall, J.A. Parkinson, I.H. Sadler, J.C. Lindon, and J.K. Nicholson Analysis of biological fluids using 600 MHz proton NMR spectroscopy: application of homonuclear two-dimensional J-resolved spectroscopy to urine and blood plasma for spectral simplification and assignment J Pharm Biomed Anal 11 1993 21 31
8. A.H. Zhang, H. Sun, S. Qiu, and X.J. Wang NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis Magn Reson Chem 51 2013 549 556
9. E. Holmes, P.J. Foxall, and J.K. Nicholson Proton NMR analysis of plasma from renal failure patients: evaluation of sample preparation and spectral-editing methods J Pharm Biomed Anal 8 1990 955 958
10. H.A. Mutsaers, U.F. Engelke, M.J. Wilmer, and et al. Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients PLoS One 8 2013 e71199
11. J.Y. Choi, Y.J. Yoon, H.J. Choi, and et al. Dialysis modality-dependent changes in serum metabolites: accumulation of inosine and hypoxanthine in patients on haemodialysis Nephrol Dial Transplant 26 2011 1304 1313
12. I. Ando, K. Takeuchi, S. Oguma, and et al. (1)H NMR spectroscopic quantification of plasma metabolites in dialysate during hemodialysis Magn Reson Med Sci 12 2013 129 135
13. J.T. Pearce, T.J. Athersuch, T.M. Ebbels, J.C. Lindon, J.K. Nicholson, and H.C. Keun Robust algorithms for automated chemical shift calibration of 1D 1H NMR spectra of blood serum Anal Chem 80 2008 7158 7162
14. R.J.O. Torgrip, K.M. Aberg, E. Alm, I. Schuppe-Koistinen, and J. Lindberg A note on normalization of biofluid 1D H-1-NMR data Metabolomics 4 2008 114 121
15. M. Bylesjo, M. Rantalainen, O. Cloarec, J.K. Nicholson, E. Holmes, and J. Trygg OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification J Chemom 20 2006 341 351
16. F. Pesarin Multivariate Permutation Tests: With Applications in Biostatistics 2001 John Wiley & Sons New York
17. S. Wold, M. Sjostrom, and L. Eriksson PLS-regression: a basic tool of chemometrics Chemometr Intell Lab Syst 58 2001 109 130
18. M.A. Bain, R. Faull, G. Fornasini, R.W. Milne, and A.M. Evans Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis Nephrol Dial Transplant 21 2006 1300 1304
19. A.R. Tricker, B. Pfundstein, T. Kalble, and R. Preussmann Secondary amine precursors to nitrosamines in human saliva, gastric-juice, blood, urine and feces Carcinogenesis 13 1992 563 568
20. N. Neirynck, R. Vanholder, E. Schepers, S. Eloot, A. Pletinck, and G. Glorieux An update on uremic toxins Int Urol Nephrol 45 2013 139 150
21. S. Bijlsma, L. Bobeldijk, E.R. Verheij, and et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation Anal Chem 78 2006 567 574
22. S. Wiklund, E. Johansson, L. Sjostrom, and et al. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models Anal Chem 80 2008 115 122
23. N.M. Laird, C.S. Berkey, and E.G. Lowrie Modeling success or failure of dialysis therapy - the 'National-Cooperative-Dialysis-Study Kidney Int Suppl 1983 S101 S106
24. F.A. Gotch, and J.A. Sargent A mechanistic analysis of the National Cooperative Dialysis Study (Ncds) Kidney Int Suppl 28 1985 526 534
25. R. Vanholder, R. DeSmet, and G. Lesaffer Dissociation between dialysis adequacy and Kt/V Semin Dial 15 2002 3 7
26. R. Vanholder, S. Eloot, and W. Van Biesen "Difficult to remove" uremic toxins Semin Dial 21 2008 407 409
27. D. Schneditz, and J.T. Daugirdas Compartment effects in hemodialysis Semin Dial 14 2001 271 277
28. J.K. Leypoldt, A.K. Cheung, and R.B. Deeter Rebound kinetics of beta2-microglobulin after hemodialysis Kidney Int Suppl 56 1999 1571 1577
29. S. Eloot, W. Van Biesen, G. Glorieux, N. Neirynck, A. Dhondt, and R. Vanholder Does the adequacy parameter Kt/V-urea reflect uremic toxin concentrations in hemodialysis patients? PLoS One 8 2013 e76838
30. J.S. Moon, J.E. Lee, and J.S. Yoon Variation in serum creatinine level is correlated to risk of type 2 diabetes Endocrinol Metab (Seoul) 28 2013 207 213
31. E.U. Nwose, P. Bwititi, N.G. Cann, and E. Butkowski Low serum creatinine levels as risk factor of diabetes mellitus: prediabetes considerations Afr J Med Med Sci 40 2011 119 122
32. B.S. Nayak, D.M. Butcher, S. Bujhawan, and et al. Association of low serum creatinine, abnormal lipid profile, gender, age and ethnicity with type 2 diabetes mellitus in Trinidad and Tobago Diabetes Res Clin Pract 91 2011 342 347
33. T.W. Meyer, and T.H. Hostetter Approaches to uremia J Am Soc Nephrol 25 2014 2151 2158
34. D. Rodrigues, C. Jeronimo, R. Henrique, and et al. Biomarkers in bladder cancer: a metabolomic approach using in vitro and ex vivo model systems Int J Cancer 2016 http://dx.doi.org/10.1002/ijc.30016 [Epub ahead of print]
35. L. Puchades-Carrasco, R. Lecumberri, J. Martinez-Lopez, and et al. Multiple myeloma patients have a specific serum metabolomic profile that changes after achieving complete remission Clin Cancer Res 19 2013 4770 4779
36. A. Smolinska, L. Blanchet, L.M. Buydens, and S.S. Wijmenga NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review Anal Chim Acta 750 2012 82 97
37. R. Godelmann, F. Fang, E. Humpfer, and et al. Targeted and nontargeted wine analysis by (1)h NMR spectroscopy combined with multivariate statistical analysis. Differentiation of important parameters: grape variety, geographical origin, year of vintage J Agric Food Chem 61 2013 5610 5619
38. V. Sirolli, C. Rossi, A. Di Castelnuovo, and et al. Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprint Blood Transfus 10 Suppl 2 2012 s78 s88
39. E. Sato, M. Kohno, M. Yamamoto, T. Fujisawa, K. Fujiwara, and N. Tanaka Metabolomic analysis of human plasma from haemodialysis patients Eur J Clin Invest 41 2011 241 255
40. F. Duranton, U. Lundin, N. Gayrard, and et al. Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function Clin J Am Soc Nephrol 9 2014 37 45
41. A.C. Dona, B. Jimenez, H. Schafer, and et al. Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping Anal Chem 86 2014 9887 9894
42. R.R. Forseth, E.M. Fox, D. Chung, B.J. Howlett, N.P. Keller, and F.C. Schroeder Identification of cryptic products of the gliotoxin gene cluster using NMR-based comparative metabolomics and a model for gliotoxin biosynthesis J Am Chem Soc 133 2011 9678 9681
43. J.S. Moon, J.E. Lee, and J.S. Yoon Variation in serum creatinine level is correlated to risk of type 2 diabetes Endocrinol Metab (Seoul) 28 2013 207 213
44. E.U. Nwose, P. Bwititi, N.G. Cann, and E. Butkowski Low serum creatinine levels as risk factor of diabetes mellitus: prediabetes considerations Afr J Med Med Sci 40 2011 119 122
45. B.S. Nayak, D.M. Butcher, S. Bujhawan, and et al. Association of low serum creatinine, abnormal lipid profile, gender, age and ethnicity with type 2 diabetes mellitus in Trinidad and Tobago Diabetes Res Clin Pract 91 2011 342 347
46. M. Inaba, M. Kurajoh, S. Okuno, and et al. Poor muscle quality rather than reduced lean body mass is responsible for the lower serum creatinine level in hemodialysis patients with diabetes mellitus Clin Nephrol 74 2010 266 272
47. A. Floegel, N. Stefan, Z.H. Yu, and et al. Identification of Serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach Diabetes 62 2013 639 648
48. M. Fulop, V. Murthy, A. Michilli, J. Nalamati, Q. Qian, and A. Saitowitz Serum beta-hydroxybutyrate measurement in patients with uncontrolled diabetes mellitus Arch Intern Med 159 1999 381 384